The surgeon joins the telehealth company as a partner two weeks after HHS allowed pharmacies to compound six peptides by prescription. He says there are no shortcuts.
SHERIDAN, Wyo., Nov. 11, 2026 – Two weeks after federal health officials opened the door to six peptides, Dr. Terry Dubrow launched HealthRX.com today as a partner. His first message to people curious about them is a caution. The new telehealth company offers online access to independent licensed clinicians for prescription peptide and GLP-1 care, and Dubrow says neither one is a shortcut.
Dr. Terry Dubrow connected to a polygraph for the HealthRX.com launch.
“Whether we’re talking about GLP-1s, peptides, or the next generation of medicine, there aren’t shortcuts or magic solutions,” Dubrow says. “These are real medical treatments and they deserve real medical oversight.”
On Oct. 28, the U.S. Department of Health and Human Services announced an interim policy that lets state-licensed pharmacies compound six peptides by prescription while the FDA completes its rulemaking. HealthRX.com offers those six. The policy is not FDA approval, and compounded medications are not FDA approved.
Dubrow’s caution is an unusual way to open a company that offers peptide care. HealthRX.com says it is deliberate. Every peptide on the site is a prescription treatment, and none is sold without a clinician’s review of the individual patient.
Dr. Terry Dubrow, partner in HealthRX.com.
HealthRX.com works like this. A patient answers questions online about their health and medical history. An independent licensed clinician reviews the answers and decides which treatment, if any, is appropriate. If a treatment is prescribed, it ships to the patient’s door, and the care team stays available for questions and adjustments. Completing the assessment does not guarantee a prescription.
Dubrow is a board-certified plastic surgeon and has been certified by the American Board of Obesity Medicine since December 2024. In the company’s launch film he sits connected to a polygraph and takes 23 questions, most of them about GLP-1 medication and the companies selling it online. His answers about that market are blunt.
“Look, there are a lot of telehealth companies out there,” he says. “The problem is you don’t know who’s standing behind them, who the founders are, and where they’re getting their licensed providers from.”
He does not ask patients to take his word for it either. The film opens with the line “Don’t trust me. I’m a doctor.” Asked directly whether people should trust him, Dubrow answers, “Yes, but not blindly.”
“I think you should trust me, but always trust and verify,” he says. “So even though I’m board certified, you need to trust your gut and look things up. Always research for yourself.”
HealthRX.com’s campaign line puts the same idea in five words: “Don’t trust us. Test us.”
“I want to be a part of shaping that future and helping people live healthier, better lives and that’s why I’m proud to partner with HealthRX,” Dubrow says.
Prescription peptide and GLP-1 care are available now. The launch video and the online assessment are at https://healthrx.com.
About HealthRX.com
HealthRX.com is a U.S. telehealth brand launching with Dr. Terry Dubrow as a partner. The platform facilitates online access to independent licensed clinicians for GLP-1 and prescription peptide care. Treatment is prescribed when clinically appropriate, with delivery and continuing access to care-team support. Learn more at https://healthrx.com.
Jennifer Washburn | HealthRX.com | press@healthrx.com
